Published in J Virol on May 01, 2001
Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J Virol (2002) 2.86
Selectively receptor-blind measles viruses: Identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model. J Virol (2004) 2.42
SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein. J Virol (2002) 2.09
Common variants associated with general and MMR vaccine-related febrile seizures. Nat Genet (2014) 1.81
Functional interaction between paramyxovirus fusion and attachment proteins. J Biol Chem (2008) 1.78
Efficient isolation of wild strains of canine distemper virus in Vero cells expressing canine SLAM (CD150) and their adaptability to marmoset B95a cells. J Virol (2003) 1.66
Measles virus infects both polarized epithelial and immune cells by using distinctive receptor-binding sites on its hemagglutinin. J Virol (2008) 1.62
Long untranslated regions of the measles virus M and F genes control virus replication and cytopathogenicity. J Virol (2005) 1.61
The heads of the measles virus attachment protein move to transmit the fusion-triggering signal. Nat Struct Mol Biol (2011) 1.61
Mutations in the stalk of the measles virus hemagglutinin protein decrease fusion but do not interfere with virus-specific interaction with the homologous fusion protein. J Virol (2007) 1.58
Cooperation between different RNA virus genomes produces a new phenotype. Nat Commun (2012) 1.53
Tunable and reversible drug control of protein production via a self-excising degron. Nat Chem Biol (2015) 1.52
Probing the spatial organization of measles virus fusion complexes. J Virol (2009) 1.50
A human lung carcinoma cell line supports efficient measles virus growth and syncytium formation via a SLAM- and CD46-independent mechanism. J Virol (2007) 1.39
Blue native PAGE and biomolecular complementation reveal a tetrameric or higher-order oligomer organization of the physiological measles virus attachment protein H. J Virol (2010) 1.36
Attenuation of V- or C-defective measles viruses: infection control by the inflammatory and interferon responses of rhesus monkeys. J Virol (2008) 1.36
Glycoprotein interactions in paramyxovirus fusion. Future Virol (2009) 1.36
Replication of many human viruses is refractory to inhibition by endogenous cellular microRNAs. J Virol (2014) 1.35
A vectored measles virus induces hepatitis B surface antigen antibodies while protecting macaques against measles virus challenge. J Virol (2007) 1.34
Measles virus circumvents the host interferon response by different actions of the C and V proteins. J Virol (2008) 1.32
Dynamic interaction of the measles virus hemagglutinin with its receptor signaling lymphocytic activation molecule (SLAM, CD150). J Biol Chem (2008) 1.29
Translational inhibition and increased interferon induction in cells infected with C protein-deficient measles virus. J Virol (2006) 1.28
Measles virus-induced suppression of immune responses. Immunol Rev (2010) 1.27
Measles virus selectively blind to signaling lymphocytic activation molecule (SLAM; CD150) is attenuated and induces strong adaptive immune responses in rhesus monkeys. J Virol (2010) 1.25
The matrix protein of measles virus regulates viral RNA synthesis and assembly by interacting with the nucleocapsid protein. J Virol (2009) 1.24
Efficiency of measles virus entry and dissemination through different receptors. J Virol (2002) 1.22
Triggering the measles virus membrane fusion machinery. Proc Natl Acad Sci U S A (2012) 1.20
Multiple amino acid substitutions in hemagglutinin are necessary for wild-type measles virus to acquire the ability to use receptor CD46 efficiently. J Virol (2006) 1.19
Base of the measles virus fusion trimer head receives the signal that triggers membrane fusion. J Biol Chem (2012) 1.18
Both RIG-I and MDA5 RNA helicases contribute to the induction of alpha/beta interferon in measles virus-infected human cells. J Virol (2010) 1.18
Potent host-directed small-molecule inhibitors of myxovirus RNA-dependent RNA-polymerases. PLoS One (2011) 1.18
HIV-1 infection in Zambian children impairs the development and avidity maturation of measles virus-specific immunoglobulin G after vaccination and infection. J Infect Dis (2009) 1.17
Stringent requirement for the C protein of wild-type measles virus for growth both in vitro and in macaques. J Virol (2005) 1.17
DC-SIGN and CD150 have distinct roles in transmission of measles virus from dendritic cells to T-lymphocytes. PLoS Pathog (2008) 1.15
Altered interaction of the matrix protein with the cytoplasmic tail of hemagglutinin modulates measles virus growth by affecting virus assembly and cell-cell fusion. J Virol (2007) 1.13
Measles virus interacts with human SLAM receptor on dendritic cells to cause immunosuppression. Virology (2004) 1.13
Measles virus, immune control, and persistence. FEMS Microbiol Rev (2012) 1.12
Contributions of matrix and large protein genes of the measles virus edmonston strain to growth in cultured cells as revealed by recombinant viruses. J Virol (2005) 1.12
Prolonged persistence of measles virus RNA is characteristic of primary infection dynamics. Proc Natl Acad Sci U S A (2012) 1.08
A stabilized headless measles virus attachment protein stalk efficiently triggers membrane fusion. J Virol (2013) 1.07
Target analysis of the experimental measles therapeutic AS-136A. Antimicrob Agents Chemother (2009) 1.07
Measles virus V protein inhibits NLRP3 inflammasome-mediated interleukin-1β secretion. J Virol (2011) 1.06
Measles virus infects and suppresses proliferation of T lymphocytes from transgenic mice bearing human signaling lymphocytic activation molecule. J Virol (2003) 1.06
Monkey CV1 cell line expressing the sheep-goat SLAM protein: a highly sensitive cell line for the isolation of peste des petits ruminants virus from pathological specimens. J Virol Methods (2011) 1.05
Single endemic genotype of measles virus continuously circulating in China for at least 16 years. PLoS One (2012) 1.03
Indoleamine 2,3-dioxygenase mediates cell type-specific anti-measles virus activity of gamma interferon. J Virol (2005) 1.03
Adaptation of wild-type measles virus to tissue culture. J Virol (2002) 1.02
Measles virus infection of SLAM (CD150) knockin mice reproduces tropism and immunosuppression in human infection. J Virol (2006) 1.02
Detection of RNA of mumps virus during an outbreak in a population with a high level of measles, mumps, and rubella vaccine coverage. J Clin Microbiol (2008) 1.02
High-throughput screening-based identification of paramyxovirus inhibitors. J Biomol Screen (2008) 1.02
Epithelial-mesenchymal transition abolishes the susceptibility of polarized epithelial cell lines to measles virus. J Biol Chem (2010) 1.01
Measles virus C protein interferes with Beta interferon transcription in the nucleus. J Virol (2011) 1.01
A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measles. J Virol (2010) 0.99
Generation of measles virus with a segmented RNA genome. J Virol (2006) 0.97
Measles virus attachment proteins with impaired ability to bind CD46 interact more efficiently with the homologous fusion protein. Virology (2008) 0.97
Making it to the synapse: measles virus spread in and among neurons. Curr Top Microbiol Immunol (2009) 0.96
Functional and structural characterization of neutralizing epitopes of measles virus hemagglutinin protein. J Virol (2012) 0.96
Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry. BMC Microbiol (2013) 0.96
Measles viruses possessing the polymerase protein genes of the Edmonston vaccine strain exhibit attenuated gene expression and growth in cultured cells and SLAM knock-in mice. J Virol (2008) 0.96
Oncolytic measles virus strains as novel anticancer agents. Expert Opin Biol Ther (2013) 0.95
A recombinant measles virus unable to antagonize STAT1 function cannot control inflammation and is attenuated in rhesus monkeys. J Virol (2010) 0.94
Attenuated oncolytic measles virus strains as cancer therapeutics. Curr Pharm Biotechnol (2012) 0.93
Broadly neutralizing immune responses against hepatitis C virus induced by vectored measles viruses and a recombinant envelope protein booster. J Virol (2012) 0.92
Extent of measles virus spread and immune suppression differentiates between wild-type and vaccine strains in the cotton rat model (Sigmodon hispidus). J Virol (2003) 0.92
Differential cellular immune responses to wild-type and attenuated edmonston tag measles virus strains are primarily defined by the viral phosphoprotein gene. J Med Virol (2010) 0.92
Ligand-directed gene targeting to mammalian cells by pseudotype baculoviruses. J Virol (2005) 0.91
Shared paramyxoviral glycoprotein architecture is adapted for diverse attachment strategies. Biochem Soc Trans (2010) 0.91
Successful respiratory immunization with dry powder live-attenuated measles virus vaccine in rhesus macaques. Proc Natl Acad Sci U S A (2011) 0.91
Nectin-4-dependent measles virus spread to the cynomolgus monkey tracheal epithelium: role of infected immune cells infiltrating the lamina propria. J Virol (2012) 0.91
Experimental adaptation of wild-type canine distemper virus (CDV) to the human entry receptor CD150. PLoS One (2013) 0.90
Canine distemper virus associated with a lethal outbreak in monkeys can readily adapt to use human receptors. J Virol (2013) 0.90
Recombinant wild-type and edmonston strain measles viruses bearing heterologous H proteins: role of H protein in cell fusion and host cell specificity. J Virol (2002) 0.89
Comparison of the sensitivity of laboratory diagnostic methods from a well-characterized outbreak of mumps in New York city in 2009. Clin Vaccine Immunol (2013) 0.89
New measles virus genotype associated with outbreak, China. Emerg Infect Dis (2010) 0.87
Dose-dependent protection against or exacerbation of disease by a polylactide glycolide microparticle-adsorbed, alphavirus-based measles virus DNA vaccine in rhesus macaques. Clin Vaccine Immunol (2008) 0.86
Dual myxovirus screen identifies a small-molecule agonist of the host antiviral response. J Virol (2013) 0.86
The measles virus nucleocapsid protein tail domain is dispensable for viral polymerase recruitment and activity. J Biol Chem (2013) 0.85
Wild-type measles viruses with non-standard genome lengths. PLoS One (2014) 0.84
Measles virus glycoprotein complexes preassemble intracellularly and relax during transport to the cell surface in preparation for fusion. J Virol (2014) 0.84
Mutant fusion proteins with enhanced fusion activity promote measles virus spread in human neuronal cells and brains of suckling hamsters. J Virol (2012) 0.84
Genetic characterization of wild-type measles viruses isolated in China, 2006-2007. Virol J (2010) 0.84
Genetic characterization of the hemagglutinin genes of wild-type measles virus circulating in china, 1993-2009. PLoS One (2013) 0.84
Measles virus-induced immunosuppression in SLAM knock-in mice. J Virol (2010) 0.84
Adaptation to cell culture induces functional differences in measles virus proteins. Virol J (2008) 0.84
Measles virus nonstructural C protein modulates viral RNA polymerase activity by interacting with host protein SHCBP1. J Virol (2013) 0.83
The F gene of the Osaka-2 strain of measles virus derived from a case of subacute sclerosing panencephalitis is a major determinant of neurovirulence. J Virol (2010) 0.83
Measles virus-induced block of transendothelial migration of T lymphocytes and infection-mediated virus spread across endothelial cell barriers. J Virol (2008) 0.83
Expression of the Sendai (murine parainfluenza) virus C protein alleviates restriction of measles virus growth in mouse cells. Proc Natl Acad Sci U S A (2011) 0.82
Implementation of a national measles elimination program in Iran: Phylogenetic analysis of measles virus strains isolated during 2010-2012 outbreaks. PLoS One (2014) 0.81
Cytokine imbalance after measles virus infection has no correlation with immune suppression. J Virol (2009) 0.81
Tannins from Hamamelis virginiana bark extract: characterization and improvement of the antiviral efficacy against influenza A virus and human papillomavirus. PLoS One (2014) 0.81
F-actin modulates measles virus cell-cell fusion and assembly by altering the interaction between the matrix protein and the cytoplasmic tail of hemagglutinin. J Virol (2012) 0.81
Vaccine-induced measles virus-specific T cells do not prevent infection or disease but facilitate subsequent clearance of viral RNA. MBio (2014) 0.80
PACT- and RIG-I-Dependent Activation of Type I Interferon Production by a Defective Interfering RNA Derived from Measles Virus Vaccine. J Virol (2015) 0.79
No evidence for an association between persistent measles virus infection and otosclerosis among patients with otosclerosis in Japan. J Clin Microbiol (2012) 0.79
Mutations in the putative dimer-dimer interfaces of the measles virus hemagglutinin head domain affect membrane fusion triggering. J Biol Chem (2013) 0.79
Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene (1991) 38.64
The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell (1993) 7.71
Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol (1993) 7.27
SLAM (CDw150) is a cellular receptor for measles virus. Nature (2000) 6.07
Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu Rev Immunol (1991) 4.27
Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. J Virol (1990) 3.60
Sequence divergence of measles virus haemagglutinin during natural evolution and adaptation to cell culture. J Gen Virol (1997) 2.00
Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains. Proc Natl Acad Sci U S A (1995) 1.89
A single amino acid change in the hemagglutinin protein of measles virus determines its ability to bind CD46 and reveals another receptor on marmoset B cells. J Virol (1998) 1.88
Clinical isolates of measles virus use CD46 as a cellular receptor. J Virol (2000) 1.72
Increased binding activity of measles virus to monkey red blood cells after long-term passage in Vero cell cultures. J Gen Virol (1994) 1.61
Differential downregulation of CD46 by measles virus strains. J Virol (1995) 1.57
Mapping amino acids of the measles virus hemagglutinin responsible for receptor (CD46) downregulation. Virology (1996) 1.56
V domain of human SLAM (CDw150) is essential for its function as a measles virus receptor. J Virol (2001) 1.45
Characterization of a cell surface glycoprotein IPO-3, expressed on activated human B and T lymphocytes. J Immunol (1993) 1.39
The hemagglutinin of recent measles virus isolates induces cell fusion in a marmoset cell line, but not in other CD46-positive human and monkey cell lines, when expressed together with the F protein. Arch Virol (1998) 1.20
Global measles control and regional elimination, 1998-1999. MMWR Morb Mortal Wkly Rep (1999) 1.15
Amino acid substitutions at position 481 differently affect the ability of the measles virus hemagglutinin to induce cell fusion in monkey and marmoset cells co-expressing the fusion protein. Arch Virol (1999) 1.03
A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains. Nature (1984) 10.02
Ly-A and Ly-B: two systems of lymphocyte isoantigens in the mouse. Proc R Soc Lond B Biol Sci (1968) 7.51
SLAM (CDw150) is a cellular receptor for measles virus. Nature (2000) 6.07
Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet (1992) 5.14
Mechanochemical coupling in actomyosin energy transduction studied by in vitro movement assay. J Mol Biol (1990) 4.78
High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes (2000) 4.55
Further implication of murine leukemia-like virs in the disorders of NZB mice. J Exp Med (1969) 3.87
Natural antibodies to the structural core protein (p24) of the human T-cell leukemia (lymphoma) retrovirus found in sera of leukemia patients in Japan. Proc Natl Acad Sci U S A (1982) 3.75
Sequence of 3,687 nucleotides from the 3' end of Sendai virus genome RNA and the predicted amino acid sequences of viral NP, P and C proteins. Nucleic Acids Res (1983) 3.62
Sequence and expression of transcripts of the human T-cell receptor beta-chain genes. Nature (1985) 3.53
Antigenic structure of cell surfaces. An immunoferritin study of the occurrence and topography of H-2' theta, and TL alloantigens on mouse cells. J Exp Med (1969) 3.53
Analysis of cDNA clones specific for human T cells and the alpha and beta chains of the T-cell receptor heterodimer from a human T-cell line. Proc Natl Acad Sci U S A (1985) 3.41
The human T cell antigen receptor is encoded by variable, diversity, and joining gene segments that rearrange to generate a complete V gene. Cell (1984) 3.41
Effects of pH on the activity of ketoconazole against Candida albicans. Antimicrob Agents Chemother (1983) 3.06
NEDD8 recruits E2-ubiquitin to SCF E3 ligase. EMBO J (2001) 2.94
Shared viral antigen of mammalian leukaemia viruses. Nature (1970) 2.84
Reconstitution of an active surface T3/T-cell antigen receptor by DNA transfer. Nature (1985) 2.84
Chromatographic separation and antigenic analysis of proteins of the oncornaviruses. II. Mammalian leukemia-sarcoma viruses. J Virol (1972) 2.84
Afadin: A novel actin filament-binding protein with one PDZ domain localized at cadherin-based cell-to-cell adherens junction. J Cell Biol (1997) 2.82
G (Gross) and H-2 cell-surface antigens: location on Gross leukemia cells by electron microscopy with visually labeled antibody. Proc Natl Acad Sci U S A (1970) 2.77
Correlation between the location of germ-line mutations in the APC gene and the number of colorectal polyps in familial adenomatous polyposis patients. Cancer Res (1992) 2.72
Use of hybrid antibody with anti-gamma-G and anti-ferritin specificities in locating cell surface antigens by electron microscopy. J Exp Med (1968) 2.62
Occurrence of natural antibody to the G (gross) leukemia antigen in mice. Cancer Res (1966) 2.57
The antibody response of mice to murine leukemia virus in spontaneous infection: absence of classical immunologic tolerance (AKR mice-complement-fixing antibodies-lymphocytic choriomeningitis virus-immunofluorescence-glomerular deposits of antigen-antibody complexes). Proc Natl Acad Sci U S A (1972) 2.54
Leukemia-associated transplantation antigens related to murine leukemia virus. The X.1 system: immune response controlled by a locus linked to H-2. J Exp Med (1973) 2.52
Better pulmonary function and prognosis with video-assisted thoracic surgery than with thoracotomy. Ann Thorac Surg (2000) 2.49
Wild-type Gross leukemia virus and the pathogenesis of the glomerulonephritis of New Zealand mice. J Exp Med (1971) 2.41
Isolation and tissue distribution of type-C virus and viral components from a gibbon ape (Hylobates lar) with lymphocytic leukemia. Virology (1978) 2.37
TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. Proc Natl Acad Sci U S A (1996) 2.31
Morbilliviruses use signaling lymphocyte activation molecules (CD150) as cellular receptors. J Virol (2001) 2.29
Position of immobilization after dislocation of the glenohumeral joint. A study with use of magnetic resonance imaging. J Bone Joint Surg Am (2001) 2.24
Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO J (2001) 2.23
Sequence analysis of the florfenicol resistance gene encoded in the transferable R-plasmid of a fish pathogen, Pasteurella piscicida. Microbiol Immunol (1996) 2.17
Wild-type Gross leukemia virus. I. Soluble antigen (GSA) in the plasma and tissues of infected mice. J Natl Cancer Inst (1968) 2.17
Construction of a human full-length cDNA bank. Gene (1994) 2.10
Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. Gene (1995) 2.05
Rearrangements of T-cell receptor gene YT35 in human DNA from thymic leukaemia T-cell lines and functional T-cell clones. Nature (1984) 1.96
Detection of resistance factors in fish pathogen Aeromonas liquefaciens. J Gen Microbiol (1971) 1.88
Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. Science (1999) 1.85
Suspension culture of a pigment-producing cell line derived from a human malignant melanoma. J Natl Cancer Inst (1968) 1.84
New visual markers of antibody for electron microscopy. Nature (1969) 1.83
Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res (1994) 1.80
Wild-type Gross leukemia virus. II. Influence of immunogenetic factors on natural transmission and on the consequences of infection. J Natl Cancer Inst (1968) 1.79
Neural restrictive silencer factor recruits mSin3 and histone deacetylase complex to repress neuron-specific target genes. Proc Natl Acad Sci U S A (1999) 1.78
Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis. J Exp Med (2000) 1.77
Somatic rearrangement of T-cell antigen receptor gene in human T-cell malignancies. Proc Natl Acad Sci U S A (1985) 1.76
Chemical and immunological studies on mycobacterial polysaccharides. 1. Purification and properties of polysaccharides from human tubercle bacilli. J Bacteriol (1968) 1.74
A new cis-acting element for RNA replication within the 5' noncoding region of poliovirus type 1 RNA. J Virol (1995) 1.70
Detection of cerebrospinal fluid leakage: initial experience with three-dimensional fast spin-echo magnetic resonance myelography. Acta Radiol (2008) 1.63
A human T cell-specific cDNA clone (YT16) encodes a protein with extensive homology to a family of protein-tyrosine kinases. Eur J Immunol (1986) 1.62
Detection of H-2 antigens on mouse spermatozoa by the cytotoxicity test. Nature (1970) 1.62
Viral and cellular surface antigens of murine leukemias and myelomas. Serological analysis by immunoelectron microscopy. J Exp Med (1972) 1.62
Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46. J Biol Chem (1995) 1.59
[Relationship between chilliness of the limbs and daily-life conditions in young females]. Nihon Eiseigaku Zasshi (1995) 1.57
Cell surface antigens: serial sectioning of single cells as an approach to topographical analysis. Science (1971) 1.56
Conservation of the biochemical mechanisms of signal transduction among mammalian Notch family members. Proc Natl Acad Sci U S A (2001) 1.54
Presence of antigen common to avian tumor viral envelope antigen in normal chick embryo cells. Virology (1973) 1.54
Predominant activation and expansion of V gamma 9-bearing gamma delta T cells in vivo as well as in vitro in Salmonella infection. J Clin Invest (1992) 1.52
Therapeutic controversy: Screening for postpartum thyroiditis. J Clin Endocrinol Metab (1999) 1.50
Ulcerative colitis with skip lesions at the mouth of the appendix: a clinical study. Am J Gastroenterol (1998) 1.49
CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J Clin Endocrinol Metab (1995) 1.49
Nucleotide sequence analysis of the class G tetracycline resistance determinant from Vibrio anguillarum. Microbiol Immunol (1992) 1.48
Anti-thymocyte globulin and prednisone immunotherapy of recent onset type 1 diabetes mellitus. Diabetes Res (1985) 1.48
Graves' disease in severe combined immunodeficient mice. J Clin Endocrinol Metab (1995) 1.46
V domain of human SLAM (CDw150) is essential for its function as a measles virus receptor. J Virol (2001) 1.45
Empyema and mediastinitis complicating retropharyngeal abscess. Thorax (1994) 1.45
MEK kinase is involved in tumor necrosis factor alpha-induced NF-kappaB activation and degradation of IkappaB-alpha. J Biol Chem (1996) 1.45
Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Cancer Res (1996) 1.45
Anbtibiotics and drug resistance in animals. R factors related to fish culturing. Ann N Y Acad Sci (1971) 1.44
Non-familial olivopontocerebellar atrophy combined with late onset Alzheimer's disease: a clinico-pathological case report. J Neurol Sci (1998) 1.44
Persistent abnormalities of the metabolism of an oral glucose load in insulin-treated type I diabetics. Metabolism (1989) 1.43
Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load. J Clin Invest (1988) 1.42
Cloning and functional expression of a cytochrome P450 cDNA encoding 2-hydroxyisoflavanone synthase involved in biosynthesis of the isoflavonoid skeleton in licorice. Plant Physiol (1999) 1.40
Raltegravir can be used safely in HIV-1-infected patients treated with warfarin. Int J STD AIDS (2012) 1.40
Bilirubin adsorption therapy and subsequent liver transplantation cured severe bilirubin encephalopathy in a long-term survival patient with Crigler-Najjar disease type I. Intern Med (2000) 1.40
A case of recurrent ameloblastoma developing in an autogenous iliac bone graft 20 years after the initial treatment. Dentomaxillofac Radiol (2006) 1.39
Probable Langevin-like director reorientation in an interface-induced disordered SmC*-like state of liquid crystals characterized by frustration between ferro- and antiferroelectricity. Phys Rev Lett (2001) 1.39
Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus. J Natl Cancer Inst (1974) 1.38
Hyaluronan serves a novel role in airway mucosal host defense. FASEB J (2001) 1.38
Mode of disulfide bond formation of a heat-stable enterotoxin (STh) produced by a human strain of enterotoxigenic Escherichia coli. FEBS Lett (1987) 1.37
Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience. Cancer (1998) 1.37
A novel pathogenesis of megacolon in Ncx/Hox11L.1 deficient mice. J Clin Invest (1997) 1.37
Antigenic properties of endogenous type-C viruses from spontaneously transformed clones of BALB-3T3. Proc Natl Acad Sci U S A (1973) 1.36
Detection of R factors in naturally occurring Vibrio anguillarum strains. Antimicrob Agents Chemother (1974) 1.35
Gene rearrangement in cells with natural killer activity and expression of the beta-chain of the T-cell antigen receptor. Nature (1985) 1.34
Anaphylactic symptoms due to chlorhexidine gluconate. Arch Dermatol (1989) 1.33
Movement of single myosin filaments and myosin step size on an actin filament suspended in solution by a laser trap. Biophys J (1994) 1.33
Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4). FEBS Lett (2001) 1.31
Wild-type gross leukemia virus: classification of soluble antigens (GSA). J Virol (1972) 1.31
Isolation, characterization, and transplantation of bone marrow-derived hepatocyte stem cells. Biochem Biophys Res Commun (2001) 1.31
Development of a highly specific recombinant Toxocara canis second-stage larva excretory-secretory antigen for immunodiagnosis of human toxocariasis. J Clin Microbiol (2000) 1.30
Screening for germ-line mutations in familial adenomatous polyposis patients: 61 new patients and a summary of 150 unrelated patients. Hum Mutat (1992) 1.30
Macular configuration determined by optical coherence tomography after idiopathic macular hole surgery with or without internal limiting membrane peeling. Br J Ophthalmol (2002) 1.29
Natural occurrence of lymphocytes showing cytotoxic activity to BALB/c radiation-induced leukemia RL male 1 cells. J Natl Cancer Inst (1975) 1.28
Suppression of Gross leukemia cell-surface antigens: a kind of antigenic modulation. J Natl Cancer Inst (1972) 1.28